Identification of Key Genes Associated with Progression and Prognosis of Bladder Cancer through Integrated Bioinformatics Analysis

Differential gene expression profile between progressive and de novo muscle invasive bladder cancer and its prognostic implication

(2021) Raquel Carrasco et al.   Scientific Reports

A Correlation Study of Prognostic Risk Prediction for Colorectal Cancer Based on Autophagy Signature Genes

(2021) Haibi Zhao et al.   Frontiers in Oncology

Screening and Identification of Key Biomarkers for Bladder Cancer: A Study Based on TCGA and GEO Data

(2020) Yingkun Xu et al.   Biomed Research International

Pembrolizumab (pembro) for the treatment of patients with Bacillus Calmette-Guérin (BCG) unresponsive, high-risk (HR) non–muscle-invasive bladder cancer (NMIBC): Over two years follow-up of KEYNOTE-057.

(2020) Arjun Vasant Balar et al.   JOURNAL OF CLINICAL ONCOLOGY

Genomic heterogeneity in bladder cancer: challenges and possible solutions to improve outcomes

(2020) Joshua J. Meeks et al.   Nature Reviews Urology

Differential expression of MAGEA6 toggles autophagy to promote pancreatic cancer progression

(2020) Yiu Huen Tsang et al.   eLife

Pan-Cancer Analyses Reveal Genomic Features of FOXM1 Overexpression in Cancer

(2019) Carter Barger et al.   Cancers

The identification of new biomarkers for bladder cancer: A study based on TCGA and GEO datasets

(2019) Junyi Hu et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Cyclin D-Cdk4,6 Drives Cell-Cycle Progression via the Retinoblastoma Protein’s C-Terminal Helix

(2019) Benjamin R. Topacio et al.   MOLECULAR CELL

GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis

(2019) Zefang Tang et al.   NUCLEIC ACIDS RESEARCH

Metascape provides a biologist-oriented resource for the analysis of systems-level datasets

(2019) Yingyao Zhou et al.   Nature Communications

Tissue Expression of Melanoma-associated Antigen A6 and Clinical Characteristics of Gastric Cancer

(2019) MIYO ENDO et al.   ANTICANCER RESEARCH

FOXM1 predicts disease progression in non-muscle invasive bladder cancer

(2018) Sebastien Rinaldetti et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

BUB1 Is Essential for the Viability of Human Cells in which the Spindle Assembly Checkpoint Is Compromised

(2018) Jonne A. Raaijmakers et al.   Cell Reports

FOXM1 overexpression is associated with adverse outcome and predicts response to intravesical instillation therapy in stage pT1 non-muscle-invasive bladder cancer

(2018) Johannes Breyer et al.   BJU INTERNATIONAL

CDKN2A as transcriptomic marker for muscle-invasive bladder cancer risk stratification and therapy decision-making

(2018) Thomas S. Worst et al.   Scientific Reports

The Dominant Role of Forkhead Box Proteins in Cancer

(2018) Duc-Hiep Bach et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Prediction models for progression of non-muscle-invasive bladder cancer: A review

(2017) Yasuhisa Fujii   INTERNATIONAL JOURNAL OF UROLOGY

Keratin 23 promotes telomerase reverse transcriptase expression and human colorectal cancer growth

(2017) Ningning Zhang et al.   Cell Death & Disease

APC/C Dysfunction Limits Excessive Cancer Chromosomal Instability

(2017) Laurent Sansregret et al.   Cancer Discovery

MAGE-A family expression is correlated with poor survival of patients with lung adenocarcinoma: a retrospective clinical study based on tissue microarray

(2016) Meixiang Sang et al.   JOURNAL OF CLINICAL PATHOLOGY

Update on the management of non-muscle invasive bladder cancer

(2016) Saad Aldousari et al.   CUAJ-Canadian Urological Association Journal

Degradation of AMPK by a Cancer-Specific Ubiquitin Ligase

(2015) Carlos T. Pineda et al.   CELL

The MAGE protein family and cancer

(2015) Jenny L Weon et al.   CURRENT OPINION IN CELL BIOLOGY

Dissecting the roles of human BUB1 in the spindle assembly checkpoint

(2015) M. Vleugel et al.   JOURNAL OF CELL SCIENCE

Targeting CDK4 and CDK6: From Discovery to Therapy

(2015) C. J. Sherr et al.   Cancer Discovery

Expression Signature Defined by FOXM1-CCNB1 Activation Predicts Disease Recurrence in Non-Muscle-Invasive Bladder Cancer

(2014) S.-K. Kim et al.   CLINICAL CANCER RESEARCH

Overexpression of cysteine cathepsin L is a marker of invasion and metastasis in ovarian cancer

(2014) WEI ZHANG et al.   ONCOLOGY REPORTS

Cyclin D activates the Rb tumor suppressor by mono-phosphorylation

(2014) Anil M Narasimha et al.   eLife

A Kinase-Independent Function of CDK6 Links the Cell Cycle to Tumor Angiogenesis

(2013) Karoline Kollmann et al.   CANCER CELL

Cathepsin L inhibition by the small molecule KGP94 suppresses tumor microenvironment enhanced metastasis associated cell functions of prostate and breast cancer cells

(2013) Dhivya R. Sudhan et al.   CLINICAL & EXPERIMENTAL METASTASIS

Review of S100A9 biology and its role in cancer

(2012) Joseph Markowitz et al.   BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER

Functions of S100 Proteins

(2012) R. Donato et al.   CURRENT MOLECULAR MEDICINE

The meaning of p16ink4aexpression in tumors

(2011) Agnieszka K. Witkiewicz et al.   CELL CYCLE

Clinical and Biological Significance of CDK4 Amplification in Well-Differentiated and Dedifferentiated Liposarcomas

(2009) A. Italiano et al.   CLINICAL CANCER RESEARCH

Bladder cancer

(2009) Donald S Kaufman et al.   LANCET

Role of Urinary Cathepsin B and L in the Detection of Bladder Urothelial Cell Carcinoma

(2008) Robert S. Svatek et al.   JOURNAL OF UROLOGY

Securin regulates entry into M-phase by modulating the stability of cyclin B

(2008) Petros Marangos et al.   NATURE CELL BIOLOGY